A prevalent mental health problem affecting millions of people globally is sadness. The mainstay of treating melancholy for a long time was comprised of standard medicines such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). But these therapies frequently have a long half-life and serious adverse effects. The quest for antid... https://timeexchanged.com/category/science-health/